[Cell-associated complement regulatory proteins and their relation to disease processes]
- PMID: 1723433
[Cell-associated complement regulatory proteins and their relation to disease processes]
Abstract
C3-deposition is a key step for activation of the complement system, which involves C9-mediated immunocytolysis, immunoadherence, C3 receptor-mediated phagocytosis, NK potentiation, anaphylatoxin release, and amplification of C3 activation. Foreign material is eliminated even in the preimmune stage by these complement functions. Self cells, on the other hand, must circumvent the C3-attack, so that they express complement regulatory proteins, namely C3b/C4b receptor (CR1, CD35), decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46). We herein review the properties of these regulatory proteins and discuss the relationships between disease processes and the aberrance of these regulatory proteins.
Similar articles
-
Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.J Immunol. 1990 Jul 1;145(1):238-45. J Immunol. 1990. PMID: 1694203
-
[Complement regulatory proteins CR 1, MCP, DAF, and MACIF levels in patients with Behçet's disease].Nippon Ganka Gakkai Zasshi. 1996 May;100(5):376-80. Nippon Ganka Gakkai Zasshi. 1996. PMID: 8651056 Japanese.
-
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.J Exp Med. 1995 Jan 1;181(1):151-9. doi: 10.1084/jem.181.1.151. J Exp Med. 1995. PMID: 7528766 Free PMC article.
-
Complement regulatory proteins in glomerular diseases.Kidney Int. 1998 Nov;54(5):1419-28. doi: 10.1046/j.1523-1755.1998.00130.x. Kidney Int. 1998. PMID: 9844117 Review.
-
Membrane-associated proteins regulating the complement system: functions and deficiencies.Int Rev Immunol. 1993;10(1):87-101. doi: 10.3109/08830189309051173. Int Rev Immunol. 1993. PMID: 7688019 Review. No abstract available.
Cited by
-
How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application.Front Immunol. 2020 Oct 29;11:593610. doi: 10.3389/fimmu.2020.593610. eCollection 2020. Front Immunol. 2020. PMID: 33193442 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous